References
- Nestler EJ, Carlezon WA. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006;59:1151–9.
- Gershon AA, Vishne T, Grunhaus L. Dopamine D2-like receptors and the antidepressant response. Biol Psychiatry 2007;61:145–53.
- De Lima MSW, Hotopf M. Benefit and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence. Drug Saf 2003;26:55–64.
- Ceskova E. Deniban in the treatment of dysthymia. Ces Slov Psychiatr 2007;103:73–9.
- Lam RW, Wan DD, Cohen NL, Kennedy SH. Combining antidepressants for treatment-resistant depression: a review. J Clin Psychiatry 2002;63:685–93.
- Stahl SM. Multifunctional drugs: a novel concept for psychopharmacology. CNS Spectr 2009;14:71–3.
- Lecrubier Y, Bahk Won-Myong, De Matos J, Briley M. The management of depression: An international naturalistic survey. Int J Clin Pract 2008;12:285–91.
- Papakostas GI. Limitations of contemporary antidepressants: tolerability. J Clin Psychiatry 2007;68(Suppl 10):11–17.
- Noble S, Benfield P. Amisulpride; a review of its clinical potential in dysthymia. CNS Drugs 1999;12:471–83.
- Coulouvrat C, Dondey-Nouvel L. Safety of amisulpride (Solian(R): a review of 11 clinical studies. Int Clin Psychopharmacol 1999;14:209–18.
- Papakostas GI. Dopaminergic-based pharmacotherapies for depression. Eur Neuropsychopharmacology 2006;16:391–402.
- Leucht S, Busch R, Haman J, Kissling W, Kane JM. Early onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended. Biol Psychiatry 2005; 57:1543–9.
- Dodd S, Horgan D, Malhi GS, Berk M. To combine or not to combine? A literature review of antidepressant combination therapy J Affect Disord 2005;89:1–11.
- Bllier P, Ward HE, Trembley P, Laberge L, Hébert C, Bergeron R. Combination af antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Am J Psychiatry 2010;167:281–8.